STOCK TITAN

Federated Hermes reports 2.75M-share stake in LifeMD (LFMD)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Federated Hermes, Inc. reports shared beneficial ownership of 2,747,655 shares of LifeMD common stock, representing 5.68% of the class as of 06/30/2026. The filing lists voting and dispositive power as shared among Federated Hermes, the Voting Shares Irrevocable Trust, and named individuals and includes Rule 13d-4 disclaimers about beneficial ownership.

Positive

  • None.

Negative

  • None.

Insights

Federated Hermes discloses a 5.68% stake (2,747,655 shares) in LifeMD.

The filing shows 2,747,655 shares and 5.68% of the outstanding class as of 06/30/2026, with voting and dispositive power reported as shared. The statement includes Rule 13d-4 disclaimers that avoid admitting beneficial ownership of managed-fund holdings.

Cash-flow treatment and any planned transactions are not stated; subsequent filings or fund disclosures would show trading intentions or portfolio actions.

Shares beneficially owned 2,747,655 shares as of 06/30/2026
Percent of class 5.68% as of 06/30/2026
CUSIP 53216B104 LifeMD common stock CUSIP
Reporting period 06/30/2026 date for reported ownership
Signature dates 07/08/2026 signatures on Schedule 13G
Schedule 13G regulatory
"Item 1. (a) Name of issuer: LifeMD, Inc.; form type Schedule 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership financial
"Item 4. Ownership (a) Amount beneficially owned: See response to Item 9"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole/Shared Voting Power regulatory
"columns showing Sole Voting Power 2,747,655.00 and Shared Voting Power 0.00"
Rule 13d-4 disclaimer regulatory
"In accordance with Rule 13d-4 under the Exchange Act... expressly disclaim beneficial ownership"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Federated Hermes report in LifeMD (LFMD)?

Federated Hermes reports beneficial ownership of 2,747,655 shares, representing 5.68% of LifeMD common stock as of 06/30/2026. The filing lists shared voting and dispositive power among related entities and individuals.

Does the Schedule 13G indicate Federated Hermes controls the shares?

No. The filing shows shared voting and dispositive power and includes a Rule 13d-4 disclaimer. Federated Hermes and named trustees expressly disclaim beneficial ownership of securities held by managed funds.

What date does the ownership percentage cover in the LFMD filing?

The ownership amount and percentage are reported with an as of date of 06/30/2026. Signatures on the schedule are dated 07/08/2026, but the reported position references the June 30, 2026 reporting period.

Who is listed as having voting power over the LifeMD shares?

The schedule lists Federated Hermes, Inc., the Voting Shares Irrevocable Trust, and individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue with shared voting and dispositive power totaling 2,747,655 shares.

Does the filing disclose any planned sale or purchase of LFMD shares?

The Schedule 13G excerpt does not disclose any planned purchases or sales. It reports the ownership position and power allocations; transaction intentions or trading activity are not described in the provided text.





53216B104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G



Federated Hermes, Inc.
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:07/08/2026
Voting Shares Irrevocable Trust
Signature:/s/Thomas R. Donahue
Name/Title:Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:07/08/2026
Signature:/s/Ann C. Donahue
Name/Title:Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:07/08/2026
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:07/08/2026
Thomas R. Donahue
Signature:/s/Thomas R. Donahue
Name/Title:Thomas R. Donahue
Date:07/08/2026
Ann C. Donahue
Signature:/s/Ann C. Donahue
Name/Title:Ann C. Donahue
Date:07/08/2026
J. Christopher Donahue
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue
Date:07/08/2026

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY